Extended Data Fig. 5: Reactome pathways associated with response to neoadjuvant therapy.
From: Multi-omic machine learning predictor of breast cancer therapy response
a, b, Reactome pathway enrichment showing pathways associated with (a) pCR versus residual disease, (b) degree of residual disease following neoadjuvant therapy.
